Literature DB >> 28135352

Implementation of Lung Cancer Screening in the Veterans Health Administration.

Linda S Kinsinger1, Charles Anderson2, Jane Kim1, Martha Larson1, Stephanie H Chan1, Heather A King3,4, Kathryn L Rice5, Christopher G Slatore6, Nichole T Tanner7, Kathleen Pittman1, Robert J Monte8, Rebecca B McNeil3,4, Janet M Grubber4, Michael J Kelley4,9, Dawn Provenzale3,4, Santanu K Datta3,4, Nina S Sperber3,4, Lottie K Barnes3, David H Abbott3, Kellie J Sims3, Richard L Whitley3, R Ryanne Wu3,4, George L Jackson3,4.   

Abstract

Importance: The US Preventive Services Task Force recommends annual lung cancer screening (LCS) with low-dose computed tomography for current and former heavy smokers aged 55 to 80 years. There is little published experience regarding implementing this recommendation in clinical practice.
Objectives: To describe organizational- and patient-level experiences with implementing an LCS program in selected Veterans Health Administration (VHA) hospitals and to estimate the number of VHA patients who may be candidates for LCS. Design, Setting, and Participants: This clinical demonstration project was conducted at 8 academic VHA hospitals among 93 033 primary care patients who were assessed on screening criteria; 2106 patients underwent LCS between July 1, 2013, and June 30, 2015. Interventions: Implementation Guide and support, full-time LCS coordinators, electronic tools, tracking database, patient education materials, and radiologic and nodule follow-up guidelines. Main Outcomes and Measures: Description of implementation processes; percentages of patients who agreed to undergo LCS, had positive findings on results of low-dose computed tomographic scans (nodules to be tracked or suspicious findings), were found to have lung cancer, or had incidental findings; and estimated number of VHA patients who met the criteria for LCS.
Results: Of the 4246 patients who met the criteria for LCS, 2452 (57.7%) agreed to undergo screening and 2106 (2028 men and 78 women; mean [SD] age, 64.9 [5.1] years) underwent LCS. Wide variation in processes and patient experiences occurred among the 8 sites. Of the 2106 patients screened, 1257 (59.7%) had nodules; 1184 of these patients (56.2%) required tracking, 42 (2.0%) required further evaluation but the findings were not cancer, and 31 (1.5%) had lung cancer. A variety of incidental findings, such as emphysema, other pulmonary abnormalities, and coronary artery calcification, were noted on the scans of 857 patients (40.7%). Conclusions and Relevance: It is estimated that nearly 900 000 of a population of 6.7 million VHA patients met the criteria for LCS. Implementation of LCS in the VHA will likely lead to large numbers of patients eligible for LCS and will require substantial clinical effort for both patients and staff.

Entities:  

Mesh:

Year:  2017        PMID: 28135352     DOI: 10.1001/jamainternmed.2016.9022

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  107 in total

1.  Examining Gender Differences in Lung Cancer Screening.

Authors:  Simran Randhawa; Shelby R Sferra; Chandra Das; Larry R Kaiser; Grace X Ma; Cherie P Erkmen
Journal:  J Community Health       Date:  2020-10

2.  Understanding lung cancer screening behaviour using path analysis.

Authors:  Lisa Carter-Harris; James E Slaven; Patrick O Monahan; Claire Burke Draucker; Emilee Vode; Susan M Rawl
Journal:  J Med Screen       Date:  2019-09-24       Impact factor: 2.136

Review 3.  Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.

Authors:  Ashwin A Kotwal; Mara A Schonberg
Journal:  Cancer J       Date:  2017 Jul/Aug       Impact factor: 3.360

4.  Early diagnosis of lung cancer: is rapid access CT scanning the answer?

Authors:  Demetris Tsiakkis; Yitka Graham; Julie Cox
Journal:  Br J Gen Pract       Date:  2019-02       Impact factor: 5.386

5.  Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement.

Authors:  Ashish Rai; V Paul Doria-Rose; Gerard A Silvestri; K Robin Yabroff
Journal:  J Natl Cancer Inst       Date:  2019-04-01       Impact factor: 13.506

6.  Establishing a Cohort and a Biorepository to Identify Biomarkers for Early Detection of Lung Cancer: The Nashville Lung Cancer Screening Trial Cohort.

Authors:  Dhairya A Lakhani; Sheau-Chiann Chen; Sanja Antic; Anel Muterspaugh; Christine Cook; Nancy Liu; Hina Shujat; Sophie Jouan; Brandon Winston; Kim Fields; Janelle Wenstrup; Sara L Block; Amy Hinton; Alexandra Miller; Sarah Atmajoana; John T Helton; Khushbu Patel; Aneri B Balar; Katrina Brewer; Subodh Nag; Rajbir Singh; Anthony Disher; Luis Huerta; Richard Fremont; Otis Rickman; Heidi Chen; Rosana Eisenberg; Kim L Sandler; Alexis Paulson; Ronald C Walker; Chirayu Shah; Gary T Smith; Bennett Landman; Stephen Deppen; Eric L Grogan; Melinda C Aldrich; Pierre P Massion
Journal:  Ann Am Thorac Soc       Date:  2021-07

7.  Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting.

Authors:  Jinhai Huo; Ying Xu; Tommy Sheu; Robert J Volk; Ya-Chen Tina Shih
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

8.  Assessment of Lung Cancer Screening Program Websites.

Authors:  Stephen D Clark; Daniel S Reuland; Chineme Enyioha; Daniel E Jonas
Journal:  JAMA Intern Med       Date:  2020-06-01       Impact factor: 21.873

9.  Barriers to and Interest in Lung Cancer Screening Among Latino and Non-Latino Current and Former Smokers.

Authors:  Sanja Percac-Lima; Jeffrey M Ashburner; Steven J Atlas; Nancy A Rigotti; Efren J Flores; Salome Kuchukhidze; Elyse R Park
Journal:  J Immigr Minor Health       Date:  2019-12

10.  Using DNA methylation to validate an electronic medical record phenotype for smoking.

Authors:  Kathleen A McGinnis; Amy C Justice; Janet P Tate; Henry R Kranzler; Hilary A Tindle; William C Becker; John Concato; Joel Gelernter; Boyang Li; Xinyu Zhang; Hongyu Zhao; Kristina Crothers; Ke Xu
Journal:  Addict Biol       Date:  2018-10-04       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.